IDEXX Laboratories, Inc. Common Stock IDXX
i
Market dataready · fetched 2026-11-13T02:51:21.351Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T21:23:33.334613601Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T02:51:20.858003+00:00
IDEXX Laboratories, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 733.24 | 37.3% | 5.6% | 668.40 | 36.7% | 4.9% |
| 25Δ | 723.54 | 33.5% | 4.4% | 675.58 | 34.4% | 4.0% |
| 30Δ | 716.89 | 31.3% | 3.6% | 682.32 | 31.4% | 3.2% |
| 35Δ | 711.55 | 30.0% | 3.0% | 687.07 | 30.4% | 2.7% |
| 40Δ | 707.23 | 30.3% | 2.6% | 691.50 | 30.0% | 2.2% |
| 45Δ | 703.34 | 31.2% | 2.3% | 695.44 | 30.4% | 2.0% |
| 50Δ | 699.41 | 31.9% | 2.0% | 699.37 | 30.8% | 1.7% |
| 55Δ | 695.32 | 31.6% | 1.7% | 703.40 | 30.8% | 1.4% |
| 60Δ | 691.22 | 31.3% | 1.5% | 707.46 | 30.6% | 1.2% |
| 65Δ | 686.81 | 31.4% | 1.2% | 711.80 | 30.6% | 1.0% |
| 70Δ | 682.28 | 31.6% | 1.0% | 716.63 | 31.0% | 0.8% |
| 75Δ | 676.90 | 32.4% | 0.8% | 721.66 | 31.2% | 0.6% |
| 80Δ | 670.68 | 33.6% | 0.7% | 727.10 | 30.9% | 0.4% |
20Δ
- Pseudo strike
- 733.24
- IV
- 37.3%
- B/E move
- 5.6%
- Pseudo strike
- 668.40
- IV
- 36.7%
- B/E move
- 4.9%
25Δ
- Pseudo strike
- 723.54
- IV
- 33.5%
- B/E move
- 4.4%
- Pseudo strike
- 675.58
- IV
- 34.4%
- B/E move
- 4.0%
30Δ
- Pseudo strike
- 716.89
- IV
- 31.3%
- B/E move
- 3.6%
- Pseudo strike
- 682.32
- IV
- 31.4%
- B/E move
- 3.2%
35Δ
- Pseudo strike
- 711.55
- IV
- 30.0%
- B/E move
- 3.0%
- Pseudo strike
- 687.07
- IV
- 30.4%
- B/E move
- 2.7%
40Δ
- Pseudo strike
- 707.23
- IV
- 30.3%
- B/E move
- 2.6%
- Pseudo strike
- 691.50
- IV
- 30.0%
- B/E move
- 2.2%
45Δ
- Pseudo strike
- 703.34
- IV
- 31.2%
- B/E move
- 2.3%
- Pseudo strike
- 695.44
- IV
- 30.4%
- B/E move
- 2.0%
50Δ
- Pseudo strike
- 699.41
- IV
- 31.9%
- B/E move
- 2.0%
- Pseudo strike
- 699.37
- IV
- 30.8%
- B/E move
- 1.7%
55Δ
- Pseudo strike
- 695.32
- IV
- 31.6%
- B/E move
- 1.7%
- Pseudo strike
- 703.40
- IV
- 30.8%
- B/E move
- 1.4%
60Δ
- Pseudo strike
- 691.22
- IV
- 31.3%
- B/E move
- 1.5%
- Pseudo strike
- 707.46
- IV
- 30.6%
- B/E move
- 1.2%
65Δ
- Pseudo strike
- 686.81
- IV
- 31.4%
- B/E move
- 1.2%
- Pseudo strike
- 711.80
- IV
- 30.6%
- B/E move
- 1.0%
70Δ
- Pseudo strike
- 682.28
- IV
- 31.6%
- B/E move
- 1.0%
- Pseudo strike
- 716.63
- IV
- 31.0%
- B/E move
- 0.8%
75Δ
- Pseudo strike
- 676.90
- IV
- 32.4%
- B/E move
- 0.8%
- Pseudo strike
- 721.66
- IV
- 31.2%
- B/E move
- 0.6%
80Δ
- Pseudo strike
- 670.68
- IV
- 33.6%
- B/E move
- 0.7%
- Pseudo strike
- 727.10
- IV
- 30.9%
- B/E move
- 0.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 30.56% | |
| 31.08% | |
| 31.09% | |
| 31.88% | |
| 34.98% | |
| 31.10% | |
| 32.35% | |
| 31.32% | |
| 31.93% | |
| 30.82% | |
| 29.87% | |
| 31.00% | |
| 30.53% | |
| 30.76% | |
| 30.80% | |
| 30.90% | |
| 32.40% | |
| 32.15% | |
| 31.99% | |
| 32.39% | |
| 33.62% | |
| 33.40% | |
| 34.85% | |
| 38.05% | |
| 33.21% | |
| 33.41% | |
| 33.46% | |
| 33.52% | |
| 34.09% | |
| 33.31% | |
| 33.38% | |
| 33.47% | |
| 33.32% | |
| 33.56% | |
| 33.41% | |
| 32.96% | |
| 34.20% | |
| 34.53% | |
| 35.28% | |
| 35.48% | |
| 35.36% | |
| 36.49% | |
| 37.16% | |
| 37.65% | |
| 35.54% | |
| 36.19% | |
| 36.76% | |
| 36.12% | |
| 36.98% | |
| 37.64% | |
| 38.11% | |
| 38.23% | |
| 37.91% | |
| 38.65% | |
| 41.20% |
Diagnostics & Research
ILMN
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and…
More →IMDX
OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
More →IQV
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is…
More →LH
Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest…
More →MEDP
Description unavailable
More →MTD
Description unavailable
More →